Interacting Drugs |
Butalbital compound and codeine vs Deferasirox |
Security Level |
 |
Mechanism |
Deferasirox: May increase the serum concentration of CYP1A2 Substrates. |
Management |
Monitor therapy |
Butalbital compound and codeine vs Deferasirox
Post Review about Butalbital compound and codeine vs Deferasirox Click here to cancel reply.
Other Interactions of Butalbital compound and codeine
Other Interactions of Deferasirox
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.